Biomarkers Market Size, Share & Trends Analysis Report By Type (Safety, Efficacy), By Application (Diagnostic, Drug Discovery & Development), By Disease (CVD, Cancer), By Region, And Segment Forecasts, 2021 - 2028

Biomarkers Market Size, Share & Trends Analysis Report By Type (Safety, Efficacy), By Application (Diagnostic, Drug Discovery & Development), By Disease (CVD, Cancer), By Region, And Segment Forecasts, 2021 - 2028

Biomarkers Market Growth & Trends

The global biomarkers market size is expected to reach USD 147.59 billion by 2028, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 14.2% over the forecast period, which is driven by increasing collaborations & funds for R&D activities, rising consumer awareness, COVID-19 pandemic, and technological advancements in disease diagnosis. Research aids in the development of effective therapies for the treatment of various diseases, such as cancer, Cardiovascular Diseases (CVDs), immunological diseases, and neurological diseases.

It has been observed that there has been an increase in public and private investments in the market. For instance, in January 2020, Johnson & Johnson Services, Inc. received a grant from Food Allergy Research & Education (FARE) worth USD 250,000 to propel the research on food allergy biomarkers. This grant is anticipated to help in the potential discovery and validation of allergy biomarkers for developing therapies. This can potentially improve the quality of life for 32 million people in the U.S. who are suffering from food allergies.

The government has also increased the funding for cancer research. For instance, in February 2020, President Trump, recently, signed a bill to fund the federal government in the U.S. along with the National Cancer Institute that received USD 6.44 billion. This funding is more than nearly USD 300 million that was allocated in 2019. These funds are expected to fuel the research associated with cancer, which is likely to have a positive impact on the market in the long run. Proactive government initiatives are driving the betterment of the reimbursement scenario in this market.

For instance, several researchers in the Asia Pacific region are involved in collaborations with regulatory authorities to validate and discover surrogate markers for use in drug development. The Japanese regulatory authorities and the government have employed a framework to promote collaborations and partnerships. Commercial insurers, generally, decide the need for biomarker testing for a patient before insuring their targeted therapy expenditures. While some insurers mandate medical evidence or prescription for biomarker testing, others may require patients to acknowledge that they are not undertaking certain therapies.

Biomarkers Market Report Highlights

  • The safety biomarkers segment accounted for the largest revenue share in 2020 due to the growing awareness about routine health checkups and rising use in the preclinical stage
  • The validation biomarkers segment is estimated to register the fastest CAGR over the forecast period due toa wide application scope in pharmaceutical companies
  • The drug discovery & development segment dominated the global market in 2020 owing to the ability to accelerate drug development in certain diseases as they can predict drug efficacy more easily than conventional clinical endpoints
  • The diagnostic segment will register the fastest CAGR over the forecast period due to the increased use of biomarkers in early-stage disease diagnosis
  • The cancer disease segment held the maximum revenue share in 2020 due to an increased prevalence of cancer and the use of biomarkers for the detection of cancer
  • CVD is estimated to be the fastest-growing disease segment over the forecast period
  • North America accounted for the maximum revenue share in 2020 due to the presence of major key players in the region and increased per capita healthcare expenditure
  • Europe, on other hand, is estimated to be the fastest-growing regional market over the forecast period
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Biomarkers Market Variables, Trends, and Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Regulatory Framework
3.3.1 Reimbursement Framework
3.3.2 Standards & Compliances
3.4 User Perspective Analysis
3.4.1 Consumer Behavior Analysis
3.5 Market Dynamics
3.5.1 Market Drivers Analysis
3.5.1.1 Increasing funding for biomarkers
3.5.1.2 Increasing prevalence of chronic diseases
3.5.1.3 Technological advancements
3.5.2 Market Restraint Analysis
3.5.2.1 Lack of reimbursement policies for biomarkers treatment
3.6 Biomarkers: Market Analysis Tools
3.6.1 Industry Analysis: Porter’s
3.6.2 Pestle Analysis
3.6.3 Major Deals And Strategic Alliances
3.6.3.1 New Product Launch
3.6.3.2 Acquisition
3.6.3.3 Partnerships
3.6.3.4 Marketing & Promotions
Chapter 4 Biomarkers Market: Segment Analysis, By Type, 2017 - 2028 (USD Million)
4.1 Definition and Scope
4.2 Type Market Share Analysis, 2020 & 2028
4.3 Segment Dashboard
4.4 Global Biomarkers Market, by Type, 2017 to 2028
4.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
4.5.1 Safety
4.5.1.1 Safety biomarkers market, 2017 - 2028 (USD Million)
4.5.2 Efficacy
4.5.2.1 Efficacy biomarkers market, 2017 - 2028 (USD Million)
4.5.3 Validation
4.5.3.1 Validation biomarkers market, 2017 - 2028 (USD Million)
Chapter 5 Biomarkers Market: Segment Analysis, By Application, 2017 - 2028 (USD Million)
5.1 Definition and Scope
5.2 Application Market Share Analysis, 2020 & 2028
5.3 Segment Dashboard
5.4 Global Biomarkers Market, by Application, 2017 to 2028
5.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
5.5.1 Diagnostics
5.5.1.1 Diagnostics market, 2017 - 2028 (USD Million)
5.5.2 Drug Discovery And Development
5.5.2.1 Drug discovery and development market, 2017 - 2028 (USD Million)
5.5.2.2 Preclinical trials
5.5.2.2.1 Introduction
5.5.2.2.2 Application
5.5.2.2.3 Regulations
5.5.2.2.4 Therapeutic gap in preclinical and clinical trial
5.5.2.2.5 Regional overview
5.5.2.2.6 Preclinical trials market, 2017- 2028 (USD Million)
5.5.2.3 Clinical trials
5.5.2.3.1 Clinical trials market, 2017- 2028 (USD Million)
5.5.3 Personalized Medicine
5.5.3.1 Personalized medicine market, 2017 - 2028 (USD Million)
5.5.4 Others
5.5.4.1 Others market, 2017 - 2028 (USD Million)
Chapter 6 Biomarkers Market: Segment Analysis, By Diseases, 2017 - 2028 (USD Million)
6.1 Definition and Scope
6.2 Diseases Market Share Analysis, 2020 & 2028
6.3 Segment Dashboard
6.4 Global Biomarkers Market, by Diseases, 2020 to 2028
6.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
6.5.1 Cancer
6.5.1.1 Cancer biomarkers market, 2017 - 2028 (USD Million)
6.5.2 Cardiovascular Diseases
6.5.2.1 Cardiovascular disease biomarkers market, 2017 - 2028 (USD Million)
6.5.3 Neurological Diseases
6.5.3.1 Neurological disease biomarkers market, 2017 - 2028 (USD Million)
6.5.4 Immunological Diseases
6.5.4.1 Immunological disease biomarkers market, 2017 - 2028 (USD Million)
6.5.5 Others
6.5.5.1 Other biomarkers market, 2017 - 2028 (USD Million)
Chapter 7 Biomarkers Market: Segment Analysis, By Region, 2017 - 2028 (USD Million)
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2020 & 2028
7.3 Regional Market Dashboard
7.4 Regional Market Snapshot
7.5 Regional Market Share and Leading Players, 2020
7.5.1 North America
7.5.2 Europe
7.5.3 Asia Pacific
7.5.4 Latin America
7.5.5 Middle East And Africa
7.6 Swot Analysis
7.6.1 North America
7.6.2 Europe
7.6.3 Asia Pacific
7.6.4 Latin America
7.6.5 Middle East And Africa
7.7 Market Size, & Forecasts, Revenue and Trend Analysis, 2020 to 2028
7.7.1 North America
7.7.1.1 North America market estimates and forecast, 2017 - 2028 (USD Million)
7.7.1.2 U.S.
7.7.1.2.1 U.S. biomarkers market, 2017 - 2028 (USD Million)
7.7.1.3 Canada
7.7.1.3.1 Canada biomarkers market, 2017 - 2028 (USD Million)
7.7.2 Europe
7.7.2.1 Europe biomarkers market, 2017 - 2028 (USD Million)
7.7.2.2 U.K.
7.7.2.2.1 U.K. biomarkers market, 2017 - 2028 (USD Million)
7.7.2.3 Germany
7.7.2.3.1 Germany biomarkers market, 2017 - 2028 (USD Million)
7.7.2.4 Spain
7.7.2.4.1 Spain biomarkers market, 2017 - 2028 (USD Million)
7.7.2.5 France
7.7.2.5.1 France biomarkers market, 2017 - 2028 (USD Million)
7.7.2.6 Italy
7.7.2.6.1 Italy biomarkers market, 2017 - 2028 (USD Million)
7.7.3 Asia Pacific
7.7.3.1 Asia Pacific biomarkers market, 2017 - 2028 (USD Million)
7.7.3.2 Japan
7.7.3.2.1 Japan biomarkers market, 2017 - 2028 (USD Million)
7.7.3.3 China
7.7.3.3.1 China biomarkers market, 2017 - 2028 (USD Million)
7.7.3.4 India
7.7.3.4.1 India biomarkers market, 2017 - 2028 (USD Million)
7.7.3.5 South Korea
7.7.3.5.1 South Korea biomarkers market, 2017 - 2028 (USD Million)
7.7.3.6 Australia
7.7.3.6.1 Australia biomarkers market, 2017 - 2028 (USD Million)
7.7.4 Latin America
7.7.4.1 Latin America biomarkers market, 2017 - 2028 (USD Million)
7.7.4.2 Brazil
7.7.4.2.1 Brazil biomarkers market, 2017 - 2028 (USD Million)
7.7.4.3 Mexico
7.7.4.3.1 Mexico biomarkers market, 2017 - 2028 (USD Million)
7.7.4.4 Argentina
7.7.4.4.1 Argentina biomarkers market, 2017 - 2028 (USD Million)
7.7.5 MEA
7.7.5.1 MEA biomarkers market, 2017 - 2028 (USD Million)
7.7.5.2 South Africa
7.7.5.2.1 South Africa biomarkers market, 2017 - 2028 (USD Million)
7.7.5.3 Saudi Arabia
7.7.5.3.1 Saudi Arabia biomarkers market, 2017 - 2028 (USD Million)
7.7.5.4 UAE
7.7.5.4.1 UAE biomarkers market, 2017 - 2028 (USD Million)
Chapter 8 Biomarkers Market: Competitive Analysis
8.1 Recent Developments and Impact Analysis, by Key Market Participants
8.1.1 Ansoff Matrix
8.1.2 Heat Map Analysis
8.2 Company Categorization
8.2.1 Innovators
8.2.2 Market Leaders
8.3 Vendor Landscape
8.3.1 List Of Key Distributors And Channel Partners
8.3.2 Key Customers
8.3.3 Key Company Market Share Analysis, 2020
8.4 Public Companies
8.4.1 Company Market Position Analysis
8.4.2 Company Market Position Analysis
8.4.3 Company Market Share, By Region
8.4.4 Competitive Dashboard Analysis
8.4.4.1 Market Differentiators
8.5 Private Companies
8.5.1 List Of Key Emerging Companies
8.6 Company Profiles
8.6.1 F. HOFFMANN-LA ROCHE LTD.
8.6.1.1 Company overview
8.6.1.2 Financial performance
8.6.1.3 Product benchmarking
8.6.1.4 Strategic initiatives
8.6.2 ABBOTT LABORATORIES
8.6.2.1 Company overview
8.6.2.2 Financial performance
8.6.2.3 Product benchmarking
8.6.2.4 Strategic initiatives
8.6.3 EPIGENOMICS AG
8.6.3.1 Company overview
8.6.3.2 Financial performance
8.6.3.3 Product benchmarking
8.6.3.4 Strategic initiatives
8.6.4 GENERAL ELECTRIC
8.6.4.1 Company overview
8.6.4.2 Financial performance
8.6.4.3 Product benchmarking
8.6.4.4 Strategic initiatives
8.6.5 JOHNSON & JOHNSON SERVICES, INC.
8.6.5.1 Company overview
8.6.5.2 Financial performance
8.6.5.3 Product benchmarking
8.6.5.4 Strategic initiatives
8.6.6 THERMO FISHER SCIENTIFIC, INC.
8.6.6.1 Company overview
8.6.6.2 Financial performance
8.6.6.3 Product benchmarking
8.6.6.4 Strategic initiatives
8.6.7 BIO-RAD LABORATORIES, INC.
8.6.7.1 Company overview
8.6.7.2 Financial performance
8.6.7.3 Product benchmarking
8.6.7.4 Strategic initiatives
8.6.8 SIEMENS HEALTHINEERS AG
8.6.8.1 Company overview
8.6.8.2 Financial performance
8.6.8.3 Product benchmarking
8.6.8.4 Strategic initiatives
8.6.9 QIAGEN
8.6.9.1 Company overview
8.6.9.2 Financial performance
8.6.9.3 Product benchmarking
8.6.9.4 Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook